U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07391306) titled 'The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.' on Jan. 13.
Brief Summary: To evaluate the efficacy and safety of Neovasculgen in interstitial cystitis and the prevention of secondary bladder shrinkage with a decrease in its volume.
Study Start Date: Feb. 16, 2024
Study Type: INTERVENTIONAL
Condition:
IC
Interstitial Cystitis and Bladder Pain Syndrome
Interstitial Cystitis, Chronic
Intervention:
DRUG: Neovasculgen(R)
The bladder is hydro-bougienaged, followed by intradetrusor injections using a cystoscopic injection needle inserted into a rigid o...